The value of pharmacist involvement in a point-of-care service, walk-in lipid screening program

Pharmacotherapy

Volumn 21, Issue 11, 2001, Pages 1403-1406

  Jafari, Mahtab ^a   Masih, Mona ^b   Emerson, Jane F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIET THERAPY; DYSLIPIDEMIA; FEMALE; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; INFORMATION SYSTEM; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PHARMACIST; PRACTICE GUIDELINE; RECURRENCE RISK; RISK FACTOR; SCREENING; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

EID: 0035160288     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.21.17.1403.34416     Document Type: Article

References (15)

1. Pharmacist-coordinated program to improve use of pharmacotherapies for reducing risk of coronary artery disease in low-income adults
2. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The scandinavian simvastatin survival study (4S)
3. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
5. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
6. Lipid research clinics coronary primary prevention trial: Results and implications
7. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
8. Study of cardiovascular risk intervention by pharmacist: A randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk
9. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system: Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care
10. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, and treatment of high blood cholesterol in adults (adult treatment panel III)
11. Pharmacist management of a hyperlipidemia clinic
12. Should hyperlipidemia in the elderly be treated?
13. Hyperlipidemia management: Opportunity for pharmacists in community practice
14. Analytic and clinical performance of two compact cholesterol-testing devices